Transcode Therapeutics, Inc. (RNAZ)
Pharmaceutical Preparations
Latest Price
$1.60
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.36
P/B Ratio
1.17
Institutional Ownership
3.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Yorkville Advisors Global, LP | 19.6K | -- | 1.94% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.5K | -- | 0.65% | -- | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 3.0K | -- | 0.29% | -- | 2026-06-30 |
| UBS Group AG | 2.9K | -- | 0.29% | -5.4K | 2026-06-30 |
| MERCER GLOBAL ADVISORS INC /ADV | 1.5K | -- | 0.15% | -- | 2026-06-30 |
| FMR LLC | 706 | -- | 0.07% | +703 | 2026-06-30 |
| Tower Research Capital LLC (TRC) | 677 | -- | 0.07% | +449 | 2026-06-30 |
| WELLS FARGO & COMPANY/MN | 55 | -- | 0.01% | -- | 2026-06-30 |
| SBI Securities Co., Ltd. | 12 | -- | 0.00% | -- | 2026-06-30 |